| 摘要 |
The invention relates to thioalkylamide of nicotinic acid 1-oxide with H2 receptor blocking activity, of formula: <IMAGE> +TR <IMAGE> and to its pharmaceutically acceptable salts, to a process for preparing same by reaction of 2-(5-dimethylaminomethylfuran-2-ylmethylthio)ethylamine with a functional derivative of nicotinic acid 1-oxide and possible salification, and to pharmaceutical compositions containing same. |
